Cargando…
Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma
Exome-sequencing for somatic mutation detection and copy number variation analysis are effective and valid methods for evaluating human cancers in current molecular medicine. We conducted target amplicon exome-sequencing analyses using PCR target enrichment and next-generation sequencing on Ion Prot...
Autores principales: | Takashima, Yasuo, Sasaki, Yasushi, Hayano, Azusa, Homma, Jumpei, Fukai, Junya, Iwadate, Yasuo, Kajiwara, Koji, Ishizawa, Shin, Hondoh, Hiroaki, Tokino, Takashi, Yamanaka, Ryuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007945/ https://www.ncbi.nlm.nih.gov/pubmed/29937999 http://dx.doi.org/10.18632/oncotarget.25463 |
Ejemplares similares
-
MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2019) -
miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2020) -
Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma
por: Takashima, Yasuo, et al.
Publicado: (2021) -
Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL
por: Takashima, Yasuo, et al.
Publicado: (2019) -
GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL
por: Takashima, Yasuo, et al.
Publicado: (2020)